Between 1991 and 1996, 268 patients were entered onto the study. Two hundred forty-three patients were assessable (127 RT + CT patients and 116 RT patients). Progression-free and overall survival are ...
Researchers from Japan today reported that the first phase II study to evaluate the efficacy and safety of durvalumab and concurrent curative radiation therapy for PD-L1-positive unresectable locally ...
For patients with brain metastases, treatment with an antibody-drug conjugate (ADC) at the same time as stereotactic radiotherapy significantly raises the risk of symptomatic radiation necrosis, a new ...
Lung cancer remains the leading cause of cancer mortality worldwide 1, the majority of lung cancer is non-small cell lung cancer (NSCLC) 2. For patients with unresectable NSCLC, radiation therapy (RT) ...
Chimeric antigen receptor–T cell (CAR-T) therapy may effectively treat B-cell non-Hodgkin lymphoma (NHL) while also improving control of autoimmune disease in patients with both conditions. There was ...
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking ...
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its global phase 3 TRIDENT trial, a randomized study in newly diagnosed glioblastoma ...
In manuscript by Wang et al., autoID group included heterogenous disorders including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjogren syndrome, polymyositis rheumatica (PMR), ...
Simultaneous radiation and immunotherapy found to be beneficial for a subset of lung cancer patients
In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results